Skip to main content
PROTEOME SCIENCES PLC logo

PROTEOME SCIENCES PLC — Investor Relations & Filings

Ticker · PRM ISIN · GB0003104196 LEI · 213800Q62ICXANKU2986 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2024-09-13 Earnings Release
Country GB United Kingdom
Listing IL PRM

About PROTEOME SCIENCES PLC

https://www.proteomics.com/

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Recent filings

Filing Released Lang Actions
Interim Results and Directorate Change
Earnings Release Classification · 1% confidence The document explicitly states it contains "Interim results for the six months ended 30 June 2024". This clearly indicates a comprehensive financial report covering a period shorter than a full year. The presence of detailed financial statements (Consolidated income statement, Consolidated balance sheet) and management commentary on the period's performance confirms it is a formal interim report, matching the definition of an Interim / Quarterly Report (IR). Although it also mentions a Directorate Change, the primary focus and bulk of the document are the financial results for H1 2024. H1 2024
2024-09-13 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of Annual General Meeting (AGM)' and confirms that 'all resolutions were duly passed'. This directly relates to the outcome of the AGM. Although it mentions the AGM, the core content is the result announcement, which aligns best with the 'AGM Information' category (AGM-R), which covers presentations and materials shared during the AGM, including the results. It is not a DEF 14A (Remuneration), 10-K (Annual Report), or ER (Earnings Release). Since the primary subject is the AGM result, AGM-R is the most specific fit.
2024-05-16 English
AGM Statement
AGM Information Classification · 1% confidence The document explicitly states it is an 'Annual General Meeting Statement' being delivered at the 'Company's Annual General Meeting ("AGM")'. This content, which is a statement made during the AGM, directly corresponds to the definition of AGM Information. Although it is filed via RNS (indicated by the RNS Number and footer), the core subject matter is the AGM statement itself, making AGM-R the most specific classification. The length is moderate, but the content is clearly focused on the meeting proceedings/update.
2024-05-16 English
Contract Win
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and contains standard boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and compliance with 'UK Market Abuse Regulations'. The content announces a specific, material business event: securing a substantial contract win exceeding £500,000 for mass spectrometry services. This is a typical regulatory announcement made via the RNS system to inform the market of significant operational developments that are not covered by more specific filings like 10-K, ER, or DIV. Given its nature as a general, material announcement distributed through the official regulatory news service, it fits best under the Regulatory Filings (RNS) category, which serves as a general category for such disclosures.
2024-04-26 English
Final Results
Earnings Release Classification · 1% confidence The document is an 'Earnings Release' (ER) because it is titled 'Final results for the year ended 31 December 2023', contains key financial highlights (revenue, EBITDA, loss after tax), and includes a CEO statement discussing performance and outlook. While it mentions the upcoming Annual Report and AGM, the document itself provides the substantive financial results for the period, fitting the definition of an Earnings Release rather than a mere announcement of a report (RPA). FY 2023
2024-04-10 English
Completion of new facility in San Diego
Regulatory Filings Classification · 1% confidence The document starts with an 'RNS Number' and is dated '02 January 2024'. It announces a specific operational update: 'Completion of new facility in San Diego'. The text is short (4190 characters) and functions as a brief announcement of a business development, not a comprehensive financial report (like 10-K or IR) or a transcript. The presence of the RNS boilerplate language at the end confirms it is a regulatory news service announcement. Since it is a specific business update that doesn't fit into categories like Capital Change (CAP), M&A (TAR), or Director Dealing (DIRS), the most appropriate general regulatory announcement category is RNS, as it is distributed via the RNS system.
2024-01-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.